메뉴 건너뛰기




Volumn 135, Issue 10, 2010, Pages 446-449

Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease- An overview of the cohort study COSYCONET;Einfluss systemischer Manifestationen und Komorbiditäten auf den klinischen Zustand und den Verlauf bei COPD: Eine Übersicht über die Kohortenstudie COSYCONET

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; EXERCISE; HEALTH STATUS; HUMAN;

EID: 77749329730     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0030-1249185     Document Type: Article
Times cited : (25)

References (6)
  • 1
    • 1442306237 scopus 로고    scopus 로고
    • The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
    • Celli B R., Cote C G., Marin J M. et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004 350 1005-1102
    • (2004) N Engl J Med , vol.350 , pp. 1005-1102
    • Celli, B.R.1    Cote, C.G.2    Marin, J.M.3
  • 2
    • 33947382261 scopus 로고    scopus 로고
    • Impact of COPD exacerbations on patient-centered outcomes
    • Cote C G., Dordelly L J., Celli B R. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007 131 696-704
    • (2007) Chest , vol.131 , pp. 696-704
    • Cote, C.G.1    Dordelly, L.J.2    Celli, B.R.3
  • 3
    • 77749325457 scopus 로고    scopus 로고
    • Comorbid conditions reported in patients with COPD recruited into clinical trials
    • (ersnet.org/ers/lr/browse)
    • Decramer M et al. Comorbid conditions reported in patients with COPD recruited into clinical trials. Poster P3589, ERS. 2007 (ersnet.org/ers/lr/ browse)
    • (2007) Poster P3589, ERS
    • Decramer, M.1
  • 4
    • 33846318149 scopus 로고    scopus 로고
    • Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
    • Kardos P, Wencker M, Glaab T, Vogelmeier C. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007 175 144-149
    • (2007) Am J Respir Crit Care Med , vol.175 , pp. 144-149
    • Kardos, P.1    Wencker, M.2    Glaab, T.3    Vogelmeier, C.4
  • 6
    • 57649167545 scopus 로고    scopus 로고
    • Metabolic profiling reveals distinct variations linked to nicotine consumption in humans
    • Wang-Sattler R, Yu Y et al. Metabolic profiling reveals distinct variations linked to nicotine consumption in humans. PLoS One 2008 3 e3863
    • (2008) PLoS One , vol.3
    • Wang-Sattler, R.1    Al Et, Y.Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.